The future of antibody-drug conjugates in endometrial cancer VJOncology 1:43 4 days ago 42 Далее Скачать
Assessing chemotherapy and immunotherapy in dMMR endometrial cancer VJOncology 0:47 11 months ago 137 Далее Скачать
Combining cemiplimab and ISA101b for the treatment of recurrent/metastatic HPV16 cervical cancer VJOncology 0:42 4 months ago 41 Далее Скачать
Improving responses to immunotherapy for patients with endometrial cancer VJOncology 1:42 1 year ago 190 Далее Скачать
KEYNOTE-A18: pembrolizumab + chemoradiotherapy improves OS in high-risk cervical cancer VJOncology 1:38 1 month ago 169 Далее Скачать
Where does immuno-oncology fit into the treatment landscape of ovarian cancer? VJOncology 2:09 3 years ago 58 Далее Скачать
PARP inhibitors in ovarian cancer: Clinical updates from SGO 2023 Touch Medical Media 59:14 1 year ago 2 695 Далее Скачать
Integrating cemiplimab + ISA101b into the treatment paradigm for recurrent HPV16 cervical cancer VJOncology 0:21 4 months ago 30 Далее Скачать
KEYNOTE-A18: pembro or placebo with chemoradiotherapy in newly diagnosed high-risk cervical cancer VJOncology 0:56 4 months ago 143 Далее Скачать
How should locally advanced cervical cancer be treated? VJOncology 2:49 7 years ago 831 Далее Скачать
Preventative and prognostic screening for BRCA mutations VJOncology 1:00 5 years ago 47 Далее Скачать
Should all platinum sensitive patients recieve PARP inhibitors? VJOncology 2:31 7 years ago 256 Далее Скачать
ESMO Gynaecological Cancers Congress: key developments in ovarian cancer VJOncology 3:31 3 years ago 98 Далее Скачать
ESMO Asia 2022: Importance of successful collaboration to improve guidelines around the world VJOncology 1:05 1 year ago 20 Далее Скачать
Expert Report on novelties in the management of gynaecological malignancies from ASCO 2022 European Society for Medical Oncology (ESMO) 7:46 2 years ago 399 Далее Скачать
What are the benefits of including chemotherapy in the treatment of endometrial cancer? VJOncology 1:36 7 years ago 1 666 Далее Скачать
